Dr. Marc Harrison officially assumed the roles of president and CEO of Intermountain Healthcare, taking over for Dr. Charles Sorenson, who has retired.
Dr. Harrison most recently served as chief of international business development for Cleveland Clinic and CEO of Cleveland Clinic Abu Dhabi.
Earlier this month, Intermountain announced that it was breaking ground on a $55 million, 120,000-square-foot Transformation Center. The building will be home to the system’s leadership training, data collection and other research efforts. Dr. Sorenson initially planned to spend his retirement in the operating room teaching residents, but later decided to lead the new center, saying the opportunity was “a little bit more unique.”
In separate news, Intermountain announced the launch of a new research and testing company called Navican Genomics, in an effort to help physicians identify personalized treatment and prevention plans for cancer.
In a press release, the health system said Navican will use an Intermountain-developed sequencing test to find and target individual mutations within cancer tumors.
“Navican gives new hope to patients and their families,” said Dr. Lincoln Nadauld, executive director of Precision Genomics at Intermountain Healthcare, and Navican adviser. “Using advanced cancer-fighting tools such as the Navican test, we give physicians confidence in knowing they are doing everything that is available to them to provide the best possible care for patients.”